Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
Top Cited Papers
- 6 October 2007
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 111 (1) , 27-44
- https://doi.org/10.1007/s10549-007-9756-8
Abstract
We analysed the clinical features, distribution of basal markers, prevalence of oncogene amplification, and outcome of triple negative (TN) compared to those of non-TN cancers in a series of adjuvant-anthracycline treated breast cancer patients.Keywords
This publication has 60 references indexed in Scilit:
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patientsCancer, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 2007
- Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast CancerJournal of Clinical Oncology, 2006
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342Breast Cancer Research, 2006
- The molecular genetics of breast cancer: The contribution of comparative genomic hybridizationPathology - Research and Practice, 2005
- Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and geneticsEndocrine-Related Cancer, 2004
- Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinomaCancer, 2003